Black Rock Inc. Arcutis Biotherapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,658,741 shares of ARQT stock, worth $61.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,658,741

Previous 5,916,546 12.54%

Holding current value

$61.9 Million

Previous $19.1 Million 245.31%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.25 - $11.77 $2.41 Million - $8.74 Million	742,195 Added 12.54%	6,658,741 $66 Million
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $3.49 Million - $9.14 Million	1,896,145 Added 47.16%	5,916,546 $19.1 Million
Q3 2023 Nov 13, 2023	SELL	$5.31 - $10.98 $1.12 Million - $2.32 Million	-210,973 Reduced 4.99%	4,020,401 $21.3 Million
Q2 2023 Aug 11, 2023	SELL	$7.51 - $15.0 $2.76 Million - $5.5 Million	-366,898 Reduced 7.98%	4,231,374 $40.3 Million
Q1 2023 May 12, 2023	SELL	$10.23 - $17.14 $6.3 Million - $10.6 Million	-615,986 Reduced 11.81%	4,598,272 $50.6 Million

Q4 2022 Feb 13, 2023	BUY	$13.96 - $20.4 $1.85 Million - $2.7 Million	132,514 Added 2.61%	5,214,258 $77.2 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $8.99 Million - $13.6 Million	503,591 Added 11.0%	5,081,744 $97.1 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $4.28 Million - $5.82 Million	262,351 Added 6.08%	4,578,153 $97.6 Million
Q1 2022 May 12, 2022	BUY	$14.38 - $22.79 $27,868 - $44,167	1,938 Added 0.04%	4,315,802 $83.1 Million
Q4 2021 Feb 10, 2022	BUY	$14.98 - $25.5 $1.77 Million - $3.01 Million	117,938 Added 2.81%	4,313,864 $89.5 Million
Q3 2021 Nov 09, 2021	SELL	$19.28 - $27.1 $1.02 Million - $1.43 Million	-52,694 Reduced 1.24%	4,195,926 $100 Million
Q2 2021 Aug 11, 2021	BUY	$24.42 - $34.75 $104 Million - $148 Million	4,248,620 New	4,248,620 $116 Million

Others Institutions Holding ARQT

# of Institutions

172

Shares Held

126M

Call Options Held

498K

Put Options Held

1.64M

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account